Nuvectis Pharma Inc (NVCT) — Net Asset Quality Index
Nuvectis Pharma Inc (NVCT) has a Net Asset Quality Index of 40.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $22.38 Million minus total liabilities of $13.29 Million yields net assets of $9.08 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read NVCT liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Nuvectis Pharma Inc Net Asset Quality Index Over Time (2020–2025)
This chart shows how Nuvectis Pharma Inc's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the index stands at 40.6%, representing net assets of $9.08 Million against total assets of $22.38 Million USD. For live market cap and overall valuation, see NVCT market cap overview.
Annual Net Asset Quality Index for Nuvectis Pharma Inc (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Nuvectis Pharma Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Nuvectis Pharma Inc (NVCT) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.1% | $18.41 Million | $31.71 Million | $13.30 Million | ▲ +5.9 pp |
| 2024 | 52.2% | $9.71 Million | $18.61 Million | $8.89 Million | ▼ -11.4 pp |
| 2023 | 63.6% | $12.20 Million | $19.18 Million | $6.98 Million | ▼ -6.1 pp |
| 2022 | 69.7% | $14.22 Million | $20.41 Million | $6.19 Million | ▲ +235.0 pp |
| 2021 | -165.4% | $-11.01 Million | $6.66 Million | $17.66 Million | ▼ -265.2 pp |
| 2020 | 99.8% | $6.65 Million | $6.66 Million | $10.00K | — |